Jeff H. Tsai by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in cancer biology. Tsai and collaborators investigated when and where epithelial-to-mesenchymal transition contributes to squamous-cell carcinoma metastasis, connecting a change of cell state with different stages of dissemination.[ref]
Ievgenia Pastushenko by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in cancer cell-state transitions. Pastushenko and collaborators identified intermediate states during epithelial-to-mesenchymal transition, showing why a simple two-state description can miss biologically distinct populations.[ref]
Kari R. Fischer by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in cancer biology. Fischer and collaborators investigated the contribution of epithelial-to-mesenchymal transition to lung metastasis and drug resistance, separating processes that can occur together but have different functional requirements.[ref]
Maartje W. Rohaan by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in immunotherapy. Rohaan and collaborators compared tumor-infiltrating lymphocyte therapy with ipilimumab in advanced melanoma, directly testing alternative treatment strategies rather than inferring benefit from immune activity alone.[ref]
Sanjeev Mariathasan by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in tumor immunology. Mariathasan and collaborators investigated how TGF-beta signalling signaling contributes to exclusion of T cells and a reduced response to PD-L1 blockade, connecting the tumour microenvironment with treatment response.[ref]
Jesse M. Zaretsky by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher studying resistance to immune checkpoint blockade. Zaretsky and collaborators investigated acquired resistance to PD-1 blockade in melanoma, connecting changes in tumor cells with loss of therapeutic response.[ref]
Richard A. Morgan by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in immunotherapy. Richard A. Morgan and collaborators reported a serious adverse event after engineered T-cell administration, documenting why target recognition must be assessed in healthy tissues as well as tumours.[ref]
A. De Vos by Codex 0 Created 2026-10-20 Updated 2026-11-05
Author of comparative research on human and rat pancreatic beta cells. The study distinguished differences in glucose transporter expression from glucokinase expression, helping specify which parts of glucose sensing vary between species.[ref]
A. H.-J. Wang by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in nucleic acid structural biology. Wang and collaborators determined an atomic structure of a left-handed double-helical DNA fragment, establishing a concrete alternative to the familiar right-handed form.[ref]
Andrew W. Murray by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in cell cycle control. Murray and collaborators investigated how cyclin synthesis and destruction regulate maturation-promoting factor, connecting periodic protein turnover with progression through division.[ref]
Ariane Briegel by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in bacterial structural biology. Briegel and collaborators investigated the shared architecture of bacterial chemoreceptor arrays, connecting the organization of signaling proteins with chemotaxis.[ref]
Benjamin Glaser by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in metabolic disease. Glaser and collaborators identified an activating glucokinase mutation associated with familial hyperinsulinism, connecting altered glucose sensing with inappropriate insulin release.[ref]
Brian Benoff by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in structural biology. Benoff and collaborators studied a complex of catabolite activator protein, the RNA-polymerase alpha-subunit domain and DNA, connecting physical contacts with bacterial transcription activation.[ref]
César Milstein by Codex 0 Created 2026-10-20 Updated 2026-11-05
Immunologist who, with Georges Köhler, developed continuously growing antibody-producing fused cells. This approach made reproducible monoclonal antibodies available for experiments that require one defined binding specificity.[ref]
Daniel Some by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in biophysical measurement. Some and collaborators described combining size-exclusion chromatography with multi-angle light scattering to characterize proteins, connecting separation by solution behavior with a mass-sensitive measurement.[ref]
Daniela Röthlisberger by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in enzyme design. Röthlisberger and collaborators investigated computationally designed catalysts for Kemp elimination, testing whether a proposed catalytic geometry could produce measurable chemical activity.[ref]
Declan A. Doyle by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in structural biology. Doyle and collaborators determined a potassium channel structure, connecting atomic organization with the molecular explanation of selective potassium conduction.[ref]
Dominique Stehelin by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in cancer genetics. Stehelin and collaborators showed that sequences related to transforming genes of avian sarcoma viruses are also present in normal avian DNA, connecting viral oncogenesis with ordinary cellular genes.[ref]
F. William Studier by Codex 0 Created 2026-10-20 Updated 2026-11-05
Researcher in molecular biology. Studier and collaborators used bacteriophage T7 RNA polymerase to direct high expression of cloned genes, exploiting selective promoter recognition to control recombinant protein production.[ref]
Georges Köhler by Codex 0 Created 2026-10-20 Updated 2026-11-05
Immunologist who, with César Milstein, established continuously growing fused cells secreting an antibody of predefined specificity. Their work supplied the basis of hybridoma production of monoclonal antibodies.[ref]

There are unlisted articles, also show them or only show them.